NCT06177379

Brief Summary

Here, this study aimed to conduct magnetic resonance neurography (MRN) of the thoracic DRGs in a cohort of healthy individuals. The acquired images will be thoroughly analyzed utilizing 3D-slicer software. We expect to furnish crucial baseline anatomical data of thoracic DRGs in healthy subjects, provide an anatomical basis for clinical investigation and therapeutic interventions.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
90

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Jan 2023

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2023

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 31, 2023

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 10, 2023

Completed
1 day until next milestone

First Submitted

Initial submission to the registry

December 11, 2023

Completed
9 days until next milestone

First Posted

Study publicly available on registry

December 20, 2023

Completed
Last Updated

December 20, 2023

Status Verified

December 1, 2023

Enrollment Period

8 months

First QC Date

December 11, 2023

Last Update Submit

December 11, 2023

Conditions

Keywords

dorsal root ganglion,Magnetic resonance neurographyvolumeneuropathic pain

Outcome Measures

Primary Outcomes (1)

  • the average DRG volume of healthy volunteers

    the average DRG volume in each thoracic segment of healthy volunteers

    202301-202312

Secondary Outcomes (1)

  • width/length ratio of DRGs

    202301-202312

Interventions

Volunteers age between 50 and 75 years

Eligibility Criteria

Age40 Years - 75 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

healthy volunteers aged between 50 and 75 years, height between 145cm to 180cm, and BMI between 18.5 to 30.

You may qualify if:

  • age between 40 and 75 years;
  • height between 145cm to 180cm;
  • BMI between 18.5 to 30.

You may not qualify if:

  • scoliosis;
  • history of thoracic surgery and pain;
  • history of spinal trauma and surgery;
  • failure or inability to complete magnetic resonance neurography (MRN) scans.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology

Wuhan, Hubei, China

Location

Related Publications (6)

  • Attal N, Bouhassira D. Advances in the treatment of neuropathic pain. Curr Opin Neurol. 2021 Oct 1;34(5):631-637. doi: 10.1097/WCO.0000000000000980.

    PMID: 34310363BACKGROUND
  • Berger AA, Liu Y, Possoit H, Rogers AC, Moore W, Gress K, Cornett EM, Kaye AD, Imani F, Sadegi K, Varrassi G, Viswanath O, Urits I. Dorsal Root Ganglion (DRG) and Chronic Pain. Anesth Pain Med. 2021 Mar 28;11(2):e113020. doi: 10.5812/aapm.113020. eCollection 2021 Apr.

    PMID: 34336621BACKGROUND
  • Malik KM, Imani F, Beckerly R, Chovatiya R. Risk of Opioid Use Disorder from Exposure to Opioids in the Perioperative Period: A Systematic Review. Anesth Pain Med. 2020 Feb 19;10(1):e101339. doi: 10.5812/aapm.101339. eCollection 2020 Feb.

    PMID: 32337175BACKGROUND
  • Attal N, Bouhassira D, Baron R. Diagnosis and assessment of neuropathic pain through questionnaires. Lancet Neurol. 2018 May;17(5):456-466. doi: 10.1016/S1474-4422(18)30071-1. Epub 2018 Mar 26.

    PMID: 29598922BACKGROUND
  • Liem L, van Dongen E, Huygen FJ, Staats P, Kramer J. The Dorsal Root Ganglion as a Therapeutic Target for Chronic Pain. Reg Anesth Pain Med. 2016 Jul-Aug;41(4):511-9. doi: 10.1097/AAP.0000000000000408.

    PMID: 27224659BACKGROUND
  • Bannister K, Sachau J, Baron R, Dickenson AH. Neuropathic Pain: Mechanism-Based Therapeutics. Annu Rev Pharmacol Toxicol. 2020 Jan 6;60:257-274. doi: 10.1146/annurev-pharmtox-010818-021524.

    PMID: 31914896BACKGROUND

MeSH Terms

Conditions

Neuralgia

Condition Hierarchy (Ancestors)

Peripheral Nervous System DiseasesNeuromuscular DiseasesNervous System DiseasesPainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Xianwei Zhang, Doctor

    Huazhong University of Science and Technology

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Clinical Professor

Study Record Dates

First Submitted

December 11, 2023

First Posted

December 20, 2023

Study Start

January 1, 2023

Primary Completion

August 31, 2023

Study Completion

December 10, 2023

Last Updated

December 20, 2023

Record last verified: 2023-12

Locations